Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Suramin in Treating Patients With Recurrent Bladder Cancer

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: November 6, 2000
Last updated: June 25, 2013
Last verified: March 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Estimated Primary Completion Date: No date given